33 Avenue Louis Pasteur
Boston, MA 02115
Genome engineering by the use of optimized TALENs, ZNFs, and CRISPR/Cas9 systems has accelerated early drug discovery efforts. In the symposium, we discuss state-of-the-art methods and applications with a view to translating basic biology to novel medical therapies. Hosted by Merck Research Laboratories and the BioPharma Research Council.